BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22208983)

  • 1. Cell-specific siRNA delivery by peptides and antibodies.
    Lee SK; Siefert A; Beloor J; Fahmy TM; Kumar P
    Methods Enzymol; 2012; 502():91-122. PubMed ID: 22208983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
    Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
    Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery.
    Dohmen C; Wagner E
    Methods Mol Biol; 2011; 683():453-63. PubMed ID: 21053149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated delivery of siRNAs for anti-HIV therapy.
    Kim SS; Subramanya S; Peer D; Shimaoka M; Shankar P
    Methods Mol Biol; 2011; 721():339-53. PubMed ID: 21431696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled siRNA-PLGA conjugate micelles for gene silencing.
    Lee SH; Mok H; Lee Y; Park TG
    J Control Release; 2011 May; 152(1):152-8. PubMed ID: 21185893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice.
    Murata N; Takashima Y; Toyoshima K; Yamamoto M; Okada H
    J Control Release; 2008 Mar; 126(3):246-54. PubMed ID: 18215787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.
    Tagalakis AD; He L; Saraiva L; Gustafsson KT; Hart SL
    Biomaterials; 2011 Sep; 32(26):6302-15. PubMed ID: 21624650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
    Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
    Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA/polymeric liposome for targeted drug and gene co-delivery.
    Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
    Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiphilic peptides with arginine and valine residues as siRNA carriers.
    Ryu DW; Kim HA; Ryu JH; Lee DY; Lee M
    J Cell Biochem; 2012 Feb; 113(2):619-28. PubMed ID: 21956817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Xu X; Xia X; Wang H; Li L; Dong W; Ma P; Liu Y
    Int J Pharm; 2016 Jun; 506(1-2):158-73. PubMed ID: 27106526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
    Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
    Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTD-DRBD siRNA delivery.
    Palm-Apergi C; Eguchi A; Dowdy SF
    Methods Mol Biol; 2011; 683():339-47. PubMed ID: 21053141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
    Katas H; Cevher E; Alpar HO
    Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.